Bruce Donzanti BSc, MSc, PhD

Bruce Donzanti has a Ph.D. in pharmacology with 20 years experience in the pharmaceutical industry, the majority of time in drug safety. He also worked in preclinical development and medical affairs. He has held both US and global positions in drug safety, such as Head, Drug Safety at Genentech and Global Head of Safety Operations at Johnson & Johnson. Currently, he is Senior Group Director of Global Pharmacovigilance Regulatory Policy at Genentech/Roche, which focuses on addressing concerns on drug safety-related topics through engaging external stakeholders and working on innovative approaches to assessing drug safety.